Two studies from the UCSF Department of Radiology and Biomedical Imaging and the Hyperpolarized MRI Technology Resource Center (HMTRC) highlight new methods to better image cancer in the kidney, brain, and pancreas. Injectable hyperpolarized compounds enable imaging scientists using MRI to precisely measure the real-time metabolism rates of cells in those organs, identifying and mapping cancerous regions. This allows patients to receive more personalized and precise diagnosis and treatment monitoring of these cancers.
Measuring Transverse Relaxation Has Potential for Improving Kidney and Brain Imaging
“Dynamic T2* relaxometry of hyperpolarized [1-13C]pyruvate MRI in the human brain and kidneys” published in Magnetic Resonance in Medicine, discusses advanced imaging techniques for quickly and accurately measuring metabolism in the brain and kidneys. In addition to measuring…
